The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are up 21%. Our forward projection puts the odds of a 10% gain over the next month near 26%. The street (22 analysts) rates it buy, with a mean price target of $240. It reported earnings in this window, a natural checkpoint for the thesis.
DICK'S Sporting Goods, Inc.
DKS · the NYSE · USD · Market cap $11.9B
FAIL · Does not pass the screenAt the last full screen
2026-09-09
Screened 2026-09-09 · the tape above runs as of 22:12 UTC · 11 Sep · two dates, stated on purpose · verdict and workings shown in full · never trimmed
This name holds its distribution label.
DICK'S Sporting Goods, Inc. holds its Distribution at $133.36. The statistical read favours the sellers, held for 8 days.
| Phase | Distribution · caution |
| Quantitative state | The statistical read favours the sellers, held for 8 days |
| Price at the screen | $133.36 |
| Valuation | 14.74 trailing · 9.93 forward price to earnings |
| Values screen | FAIL |
| Beta | 1.14 |
Five Screens, Shown in Full
Does not pass. Debt ratio
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Permissible | Core business clean | Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. | Pass |
| Debt load | 37.99% | Below 33% | Interest-bearing debt is 38.0% of its assets, above the one-third ceiling the screen allows. | Fail |
| Interest-bearing cash | 6.64% | Below 33% | Cash held in interest-bearing accounts and securities is 6.6% of assets, under the one-third limit. | Pass |
| Receivables | 0.00% | Below 49% | Money owed to the company is 0.0% of assets, under the 49% limit. | Pass |
| Revenue purity | 0.00% | Below 5% | Only 0.0% of revenue comes from non-compliant sources, under the 5% line. | Pass |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
What the Numbers Say It Is WorthThe Fair Value Range
Fair value range in USD, drawn from the 2026-09-09 screen. The gold marker is the market price at the same screen. A 59.3% margin of safety to the base estimate.
Third-party analyst targets: 23 covering, consensus Buy. The average target sits +27% from the screen price.
Reading the gap · Both our model and the analysts see meaningful upside from here.
Price History & ProjectionsWhere it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-09-09 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsDebt screen blocks sporting goods retailer
Think of a shopper piling gear into a trolley at peak season only to watch the store's own bills mount faster than sales. Dick's shows 63 percent revenue growth, 21 percent ROE and a moderate moat, yet we pass because the ethical screen flags its debt ratio as unacceptable.
The forward multiple of 13.3 times looks tempting next to a $300 fair value, and twenty-two analysts lean buy. None of that matters once the balance sheet raises red flags that our screen is built to catch.
Consumer cyclical exposure adds the usual warning that peak earnings can shrink quickly and leave a low multiple looking expensive after the fact. Analysis, not advice.
| Forward P/E | 9.9xcheap for a company growing this fast |
| Trailing P/E | 14.7xreasonably valued |
| EPS, trailing | 9.05 |
| EPS, forward | 13.43 |
| Revenue growth | +53.2%growing very fast |
| Profit margin | 4.0%barely profitable |
| Return on equity | 18.5%a solid return on shareholder capital |
| FCF yield | -6.94% |
| Dividend yield | 225.00% |
| Debt to equity | 1.39a meaningful debt load worth watching |
| Current ratio | 1.49adequate liquidity, worth monitoring |
| Beta | 1.14moves a little more than the market |
| Short interest, float | 0.13% |
| 52-week range | 120.40 - 244.38 |
| Moat | MODERATE |
| Market cap | $11.9B |
The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeDKS trades on the NYSE. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are up 21%. Our forward projection puts the odds of a 10% gain over the next month near 26%. The street (22 analysts) rates it buy, with a mean price target of $240. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are up 21%. Our forward projection puts the odds of a 10% gain over the next month near 26%. The street (22 analysts) rates it buy, with a mean price target of $240. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 8.5% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are up 21%. Our forward projection puts the odds of a 10% gain over the next month near 26%. The street (22 analysts) rates it buy, with a mean price target of $240. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are up 21%. Our forward projection puts the odds of a 10% gain over the next month near 26%. The street (22 analysts) rates it buy, with a mean price target of $240. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are up 21%. Our forward projection puts the odds of a 10% gain over the next month near 26%. The street (22 analysts) rates it buy, with a mean price target of $240. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are up 21%. Our forward projection puts the odds of a 10% gain over the next month near 26%. The street (22 analysts) rates it buy, with a mean price target of $240. It reported earnings in this window, a natural checkpoint for the thesis.
The framework has shifted from markup to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 7.8% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are up 21%. Our forward projection puts the odds of a 10% gain over the next month near 26%. The street (22 analysts) rates it buy, with a mean price target of $240. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 1.2% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are up 21%. Our forward projection puts the odds of a 10% gain over the next month near 26%. The street (22 analysts) rates it buy, with a mean price target of $240.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are up 21%. Our forward projection puts the odds of a 10% gain over the next month near 26%. The street (22 analysts) rates it buy, with a mean price target of $240.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
- Dick's Sporting Goods (DKS) Stock Slides as Market Rises: Facts to Know Before You Trade Zacks · 14 Jul 2026
- Dick's Sporting Goods could grab market share as bankrupt rival folds TheStreet · 12 Jul 2026
- NIKE Stock Outlook 2026 as Recovery Stays Uneven Across Markets Zacks · 9 Jul 2026
- Top Research Reports for Tesla, Bank of America & Merck Zacks · 8 Jul 2026
- Dick's Sporting Goods (DKS) Stock Dips While Market Gains: Key Facts Zacks · 6 Jul 2026
Headlines from third-party outlets, linked for reference: not our reporting, not advice.
Screened names in the same industry · explore each on its own page.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-04-20 | LODGE-JARRETT JULIE | Officer | 150 | · | |
| 2026-04-17 | LODGE-JARRETT JULIE | Officer | 4,140 | $925,523 | |
| 2026-04-17 | LODGE-JARRETT JULIE | Officer | 4,140 | $53,075 | |
| 2026-04-02 | STACK EDWARD W | Officer, Director and Beneficial Owner | 45,633 | · | |
| 2026-04-02 | GUPTA NAVDEEP | Chief Financial Officer | 4,890 | · | |
| 2026-04-02 | LODGE-JARRETT JULIE | Officer | 5,868 | · | |
| 2026-04-02 | RAK VLADIMIR | Chief Technology Officer | 3,260 | · | |
| 2026-04-02 | FREEMAN ANN | Officer | 3,912 | · | |
| 2026-04-02 | SLIVA RAYMOND A. JR | Officer | 3,260 | · | |
| 2026-04-02 | BARAN ELIZABETH H. | General Counsel | 1,630 | · |
Public filings, recorded as found. The full tape lives at Insider Intelligence.
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $220.25 | -2.2% | · | $978 | -2.2% |
| 2 months | $212.46 | +1.4% | · | $1,014 | +1.4% |
| 3 months | $196.32 | +9.7% | $1.25 | $1,103 | +10.3% |
| 6 months | $214.08 | +0.6% | $2.46 | $1,017 | +1.7% |
| 1 year | $178.46 | +20.7% | $4.89 | $1,234 | +23.4% |
| 2 years | $206.72 | +4.2% | $9.40 | $1,087 | +8.7% |
| 3 years | $126.09 | +70.8% | $13.50 | $1,815 | +81.5% |
| 5 years | $86.33 | +149.4% | $22.83 | $2,759 | +175.9% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever DKS does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.